| View web version » |
|
|
| Partnering for Cures is Heading to Innovation Hotspots
|
|
Recently, Forbes declared Boston and San Francisco as the biotech innovation clusters. This is why we are excited to bring Partnering for Cures (P4C) to these two cities this year. Join us for P4C Boston on July 12 and P4C San Francisco on Nov. 14.
Since 2009, P4C has been convening leaders with the experience, creativity and motivation needed to transform the medical research system. This year, we have been inspired by our new locations to do some innovating of our own, and we are changing up the way we conduct these meetings. Each meeting will be a smaller, carefully curated and highly interactive experience. In Boston, look for sessions on partnering locally for productivity and how the federal landscape impacts the ecosystem. In San Francisco, we will explore how the tech industry is influencing life sciences and why medical research needs more data scientists. Read the full post »
|
|
| PROGRAM HIGHLIGHTS |
Follow the Enactment of Key Biomedical Legislation Using the 21st Century Cures Tracker
 The 21st Century Cures Act is landmark, bipartisan legislation that touches virtually all aspects of biomedical research, medical product development and the regulatory approval process. FasterCures worked closely with Congress, federal agencies and the advocacy community throughout the legislation's journey to the president's desk. Now we are proud to debut the 21st Century Cures Tracker to monitor the implementation of the 100+ sections in Division A, which include the key provisions relevant to biomedical research and innovation. Explore this new resource today! |
|
|
|
FDA’s Workforce: New Opportunities to Strengthen the Team
 The U.S. Food and Drug Administration (FDA) has faced persistent challenges in hiring and retaining top talent in the centers that review medical products. FasterCures has been following this issue closely, and much of the problem can be traced to industry having a competitive advantage in vying for a very small pool of highly trained experts. We have identified opportunities to address this disadvantage.
|
|
|
|
|
|
|
|
In Case You Missed It: Webinar on Changing Organizational Culture in Medical R&D
Culture change is more likely to occur if you treat it as a response to opportunity, not a response to failure. This was the consensus among the speakers on FasterCures' most recent webinar. Listen to the recorded discussion for insights on what changes in scientific research could accelerate progress where decades of talking have failed.
|
|